← 產業報告目錄
Heparin Sodium Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-08頁數 134報告編號 APO-2c78d24688
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 35 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.
Report Scope
This report quantifies the global Heparin Sodium market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heparin Sodium Market by Company
Shenzhen Hepalink
Bioibérica
Nanjing King-friend
Pfizer
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Pharma Action
Baxter
Dongying Tiandong Pharmaceutical
Opocrin
Aspen Oss
Xinbai Pharmaceuticals
Yino Pharma Limited
Sichuan Deebio
Heparin Sodium Segment by Type
Oral Type
Injection Type
Heparin Sodium Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
Heparin Sodium Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heparin Sodium manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heparin Sodium by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heparin Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Heparin Sodium Market Size (2021-2032)
2.2.2 Global Heparin Sodium Sales (2021-2032)
2.2.3 Global Heparin Sodium Market Average Price (2021-2032)
2.3 Heparin Sodium by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Oral Type
2.3.3 Injection Type
2.4 Heparin Sodium by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Treatment of Venous Thromboembolism
2.4.3 Complications of Pregnancy
2.4.4 Cardioversion of Atrial Fibrillation/Flutter
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Heparin Sodium Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Heparin Sodium Sales (Kg) of Manufacturers (2021-2026)
3.3 Global Heparin Sodium Revenue of Manufacturers (2021-2026)
3.4 Global Heparin Sodium Average Price by Manufacturers (2021-2026)
3.5 Global Heparin Sodium Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Heparin Sodium, Product Type & Application
3.8 Global Manufacturers of Heparin Sodium, Established Date
3.9 Global Heparin Sodium Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Shenzhen Hepalink
4.1.1 Shenzhen Hepalink Company Information
4.1.2 Shenzhen Hepalink Business Overview
4.1.3 Shenzhen Hepalink Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Shenzhen Hepalink Heparin Sodium Product Portfolio
4.1.5 Shenzhen Hepalink Recent Developments
4.2 Bioibérica
4.2.1 Bioibérica Company Information
4.2.2 Bioibérica Business Overview
4.2.3 Bioibérica Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Bioibérica Heparin Sodium Product Portfolio
4.2.5 Bioibérica Recent Developments
4.3 Nanjing King-friend
4.3.1 Nanjing King-friend Company Information
4.3.2 Nanjing King-friend Business Overview
4.3.3 Nanjing King-friend Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.3.4 Nanjing King-friend Heparin Sodium Product Portfolio
4.3.5 Nanjing King-friend Recent Developments
4.4 Pfizer
4.4.1 Pfizer Company Information
4.4.2 Pfizer Business Overview
4.4.3 Pfizer Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Pfizer Heparin Sodium Product Portfolio
4.4.5 Pfizer Recent Developments
4.5 Dongcheng Biochemicals
4.5.1 Dongcheng Biochemicals Company Information
4.5.2 Dongcheng Biochemicals Business Overview
4.5.3 Dongcheng Biochemicals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Dongcheng Biochemicals Heparin Sodium Product Portfolio
4.5.5 Dongcheng Biochemicals Recent Developments
4.6 Changzhou Qianhong Bio-pharma
4.6.1 Changzhou Qianhong Bio-pharma Company Information
4.6.2 Changzhou Qianhong Bio-pharma Business Overview
4.6.3 Changzhou Qianhong Bio-pharma Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
4.6.5 Changzhou Qianhong Bio-pharma Recent Developments
4.7 Changshan Biochemical
4.7.1 Changshan Biochemical Company Information
4.7.2 Changshan Biochemical Business Overview
4.7.3 Changshan Biochemical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Changshan Biochemical Heparin Sodium Product Portfolio
4.7.5 Changshan Biochemical Recent Developments
4.8 Pharma Action
4.8.1 Pharma Action Company Information
4.8.2 Pharma Action Business Overview
4.8.3 Pharma Action Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Pharma Action Heparin Sodium Product Portfolio
4.8.5 Pharma Action Recent Developments
4.9 Baxter
4.9.1 Baxter Company Information
4.9.2 Baxter Business Overview
4.9.3 Baxter Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Baxter Heparin Sodium Product Portfolio
4.9.5 Baxter Recent Developments
4.10 Dongying Tiandong Pharmaceutical
4.10.1 Dongying Tiandong Pharmaceutical Company Information
4.10.2 Dongying Tiandong Pharmaceutical Business Overview
4.10.3 Dongying Tiandong Pharmaceutical Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
4.10.5 Dongying Tiandong Pharmaceutical Recent Developments
4.11 Opocrin
4.11.1 Opocrin Company Information
4.11.2 Opocrin Business Overview
4.11.3 Opocrin Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Opocrin Heparin Sodium Product Portfolio
4.11.5 Opocrin Recent Developments
4.12 Aspen Oss
4.12.1 Aspen Oss Company Information
4.12.2 Aspen Oss Business Overview
4.12.3 Aspen Oss Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Aspen Oss Heparin Sodium Product Portfolio
4.12.5 Aspen Oss Recent Developments
4.13 Xinbai Pharmaceuticals
4.13.1 Xinbai Pharmaceuticals Company Information
4.13.2 Xinbai Pharmaceuticals Business Overview
4.13.3 Xinbai Pharmaceuticals Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
4.13.5 Xinbai Pharmaceuticals Recent Developments
4.14 Yino Pharma Limited
4.14.1 Yino Pharma Limited Company Information
4.14.2 Yino Pharma Limited Business Overview
4.14.3 Yino Pharma Limited Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Yino Pharma Limited Heparin Sodium Product Portfolio
4.14.5 Yino Pharma Limited Recent Developments
4.15 Sichuan Deebio
4.15.1 Sichuan Deebio Company Information
4.15.2 Sichuan Deebio Business Overview
4.15.3 Sichuan Deebio Heparin Sodium Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Sichuan Deebio Heparin Sodium Product Portfolio
4.15.5 Sichuan Deebio Recent Developments
5 Global Heparin Sodium Market Scenario by Region
5.1 Global Heparin Sodium Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Heparin Sodium Sales by Region: 2021-2032
5.2.1 Global Heparin Sodium Sales by Region: 2021-2026
5.2.2 Global Heparin Sodium Sales by Region: 2027-2032
5.3 Global Heparin Sodium Revenue by Region: 2021-2032
5.3.1 Global Heparin Sodium Revenue by Region: 2021-2026
5.3.2 Global Heparin Sodium Revenue by Region: 2027-2032
5.4 North America Heparin Sodium Market Facts & Figures by Country
5.4.1 North America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Heparin Sodium Sales by Country (2021-2032)
5.4.3 North America Heparin Sodium Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Heparin Sodium Market Facts & Figures by Country
5.5.1 Europe Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Heparin Sodium Sales by Country (2021-2032)
5.5.3 Europe Heparin Sodium Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Heparin Sodium Market Facts & Figures by Country
5.6.1 Asia Pacific Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Heparin Sodium Sales by Country (2021-2032)
5.6.3 Asia Pacific Heparin Sodium Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Heparin Sodium Market Facts & Figures by Country
5.7.1 South America Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Heparin Sodium Sales by Country (2021-2032)
5.7.3 South America Heparin Sodium Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.7.7 Colombia
5.8 Middle East and Africa Heparin Sodium Market Facts & Figures by Country
5.8.1 Middle East and Africa Heparin Sodium Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Heparin Sodium Sales by Country (2021-2032)
5.8.3 Middle East and Africa Heparin Sodium Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Heparin Sodium Sales by Type (2021-2032)
6.1.1 Global Heparin Sodium Sales by Type (2021-2032) & (Kg)
6.1.2 Global Heparin Sodium Sales Market Share by Type (2021-2032)
6.2 Global Heparin Sodium Revenue by Type (2021-2032)
6.2.1 Global Heparin Sodium Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Heparin Sodium Revenue Market Share by Type (2021-2032)
6.3 Global Heparin Sodium Price by Type (2021-2032)
7 Segment by Application
7.1 Global Heparin Sodium Sales by Application (2021-2032)
7.1.1 Global Heparin Sodium Sales by Application (2021-2032) & (Kg)
7.1.2 Global Heparin Sodium Sales Market Share by Application (2021-2032)
7.2 Global Heparin Sodium Revenue by Application (2021-2032)
7.2.1 Global Heparin Sodium Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Heparin Sodium Revenue Market Share by Application (2021-2032)
7.3 Global Heparin Sodium Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Heparin Sodium Value Chain Analysis
8.1.1 Heparin Sodium Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Heparin Sodium Production Mode & Process
8.2 Heparin Sodium Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Heparin Sodium Distributors
8.2.3 Heparin Sodium Customers
9 Global Heparin Sodium Analyzing Market Dynamics
9.1 Heparin Sodium Industry Trends
9.2 Heparin Sodium Industry Drivers
9.3 Heparin Sodium Industry Opportunities and Challenges
9.4 Heparin Sodium Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Heparin Sodium Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Heparin Sodium Sales (Kg) of Manufacturers (2021-2026)
Table 7. Global Heparin Sodium Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Heparin Sodium Revenue of Manufacturers (2021-2026)
Table 9. Global Heparin Sodium Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Heparin Sodium Average Price (USD/Kg) of Manufacturers (2021-2026)
Table 11. Global Heparin Sodium Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Heparin Sodium, Product Type & Application
Table 14. Global Heparin Sodium Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Heparin Sodium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Shenzhen Hepalink Company Information
Table 19. Shenzhen Hepalink Business Overview
Table 20. Shenzhen Hepalink Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 21. Shenzhen Hepalink Heparin Sodium Product Portfolio
Table 22. Shenzhen Hepalink Recent Developments
Table 23. Bioibérica Company Information
Table 24. Bioibérica Business Overview
Table 25. Bioibérica Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 26. Bioibérica Heparin Sodium Product Portfolio
Table 27. Bioibérica Recent Developments
Table 28. Nanjing King-friend Company Information
Table 29. Nanjing King-friend Business Overview
Table 30. Nanjing King-friend Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 31. Nanjing King-friend Heparin Sodium Product Portfolio
Table 32. Nanjing King-friend Recent Developments
Table 33. Pfizer Company Information
Table 34. Pfizer Business Overview
Table 35. Pfizer Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 36. Pfizer Heparin Sodium Product Portfolio
Table 37. Pfizer Recent Developments
Table 38. Dongcheng Biochemicals Company Information
Table 39. Dongcheng Biochemicals Business Overview
Table 40. Dongcheng Biochemicals Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 41. Dongcheng Biochemicals Heparin Sodium Product Portfolio
Table 42. Dongcheng Biochemicals Recent Developments
Table 43. Changzhou Qianhong Bio-pharma Company Information
Table 44. Changzhou Qianhong Bio-pharma Business Overview
Table 45. Changzhou Qianhong Bio-pharma Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 46. Changzhou Qianhong Bio-pharma Heparin Sodium Product Portfolio
Table 47. Changzhou Qianhong Bio-pharma Recent Developments
Table 48. Changshan Biochemical Company Information
Table 49. Changshan Biochemical Business Overview
Table 50. Changshan Biochemical Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 51. Changshan Biochemical Heparin Sodium Product Portfolio
Table 52. Changshan Biochemical Recent Developments
Table 53. Pharma Action Company Information
Table 54. Pharma Action Business Overview
Table 55. Pharma Action Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 56. Pharma Action Heparin Sodium Product Portfolio
Table 57. Pharma Action Recent Developments
Table 58. Baxter Company Information
Table 59. Baxter Business Overview
Table 60. Baxter Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 61. Baxter Heparin Sodium Product Portfolio
Table 62. Baxter Recent Developments
Table 63. Dongying Tiandong Pharmaceutical Company Information
Table 64. Dongying Tiandong Pharmaceutical Business Overview
Table 65. Dongying Tiandong Pharmaceutical Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 66. Dongying Tiandong Pharmaceutical Heparin Sodium Product Portfolio
Table 67. Dongying Tiandong Pharmaceutical Recent Developments
Table 68. Opocrin Company Information
Table 69. Opocrin Business Overview
Table 70. Opocrin Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 71. Opocrin Heparin Sodium Product Portfolio
Table 72. Opocrin Recent Developments
Table 73. Aspen Oss Company Information
Table 74. Aspen Oss Business Overview
Table 75. Aspen Oss Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 76. Aspen Oss Heparin Sodium Product Portfolio
Table 77. Aspen Oss Recent Developments
Table 78. Xinbai Pharmaceuticals Company Information
Table 79. Xinbai Pharmaceuticals Business Overview
Table 80. Xinbai Pharmaceuticals Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 81. Xinbai Pharmaceuticals Heparin Sodium Product Portfolio
Table 82. Xinbai Pharmaceuticals Recent Developments
Table 83. Yino Pharma Limited Company Information
Table 84. Yino Pharma Limited Business Overview
Table 85. Yino Pharma Limited Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 86. Yino Pharma Limited Heparin Sodium Product Portfolio
Table 87. Yino Pharma Limited Recent Developments
Table 88. Sichuan Deebio Company Information
Table 89. Sichuan Deebio Business Overview
Table 90. Sichuan Deebio Heparin Sodium Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026)
Table 91. Sichuan Deebio Heparin Sodium Product Portfolio
Table 92. Sichuan Deebio Recent Developments
Table 93. Global Heparin Sodium Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 94. Global Heparin Sodium Sales by Region (2021-2026) & (Kg)
Table 95. Global Heparin Sodium Sales Market Share by Region (2021-2026)
Table 96. Global Heparin Sodium Sales by Region (2027-2032) & (Kg)
Table 97. Global Heparin Sodium Sales Market Share by Region (2027-2032)
Table 98. Global Heparin Sodium Revenue by Region (2021-2026) & (US$ Million)
Table 99. Global Heparin Sodium Revenue Market Share by Region (2021-2026)
Table 100. Global Heparin Sodium Revenue by Region (2027-2032) & (US$ Million)
Table 101. Global Heparin Sodium Revenue Market Share by Region (2027-2032)
Table 102. North America Heparin Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. North America Heparin Sodium Sales by Country (2021-2026) & (Kg)
Table 104. North America Heparin Sodium Sales by Country (2027-2032) & (Kg)
Table 105. North America Heparin Sodium Revenue by Country (2021-2026) & (US$ Million)
Table 106. North America Heparin Sodium Revenue by Country (2027-2032) & (US$ Million)
Table 107. Europe Heparin Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 108. Europe Heparin Sodium Sales by Country (2021-2026) & (Kg)
Table 109. Europe Heparin Sodium Sales by Country (2027-2032) & (Kg)
Table 110. Europe Heparin Sodium Revenue by Country (2021-2026) & (US$ Million)
Table 111. Europe Heparin Sodium Revenue by Country (2027-2032) & (US$ Million)
Table 112. Asia Pacific Heparin Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. Asia Pacific Heparin Sodium Sales by Country (2021-2026) & (Kg)
Table 114. Asia Pacific Heparin Sodium Sales by Country (2027-2032) & (Kg)
Table 115. Asia Pacific Heparin Sodium Revenue by Country (2021-2026) & (US$ Million)
Table 116. Asia Pacific Heparin Sodium Revenue by Country (2027-2032) & (US$ Million)
Table 117. South America Heparin Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. South America Heparin Sodium Sales by Country (2021-2026) & (Kg)
Table 119. South America Heparin Sodium Sales by Country (2027-2032) & (Kg)
Table 120. South America Heparin Sodium Revenue by Country (2021-2026) & (US$ Million)
Table 121. South America Heparin Sodium Revenue by Country (2027-2032) & (US$ Million)
Table 122. Middle East and Africa Heparin Sodium Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Middle East and Africa Heparin Sodium Sales by Country (2021-2026) & (Kg)
Table 124. Middle East and Africa Heparin Sodium Sales by Country (2027-2032) & (Kg)
Table 125. Middle East and Africa Heparin Sodium Revenue by Country (2021-2026) & (US$ Million)
Table 126. Middle East and Africa Heparin Sodium Revenue by Country (2027-2032) & (US$ Million)
Table 127. Global Heparin Sodium Sales by Type (2021-2026) & (Kg)
Table 128. Global Heparin Sodium Sales by Type (2027-2032) & (Kg)
Table 129. Global Heparin Sodium Sales Market Share by Type (2021-2026)
Table 130. Global Heparin Sodium Sales Market Share by Type (2027-2032)
Table 131. Global Heparin Sodium Revenue by Type (2021-2026) & (US$ Million)
Table 132. Global Heparin Sodium Revenue by Type (2027-2032) & (US$ Million)
Table 133. Global Heparin Sodium Revenue Market Share by Type (2021-2026)
Table 134. Global Heparin Sodium Revenue Market Share by Type (2027-2032)
Table 135. Global Heparin Sodium Price by Type (2021-2026) & (USD/Kg)
Table 136. Global Heparin Sodium Price by Type (2027-2032) & (USD/Kg)
Table 137. Global Heparin Sodium Sales by Application (2021-2026) & (Kg)
Table 138. Global Heparin Sodium Sales by Application (2027-2032) & (Kg)
Table 139. Global Heparin Sodium Sales Market Share by Application (2021-2026)
Table 140. Global Heparin Sodium Sales Market Share by Application (2027-2032)
Table 141. Global Heparin Sodium Revenue by Application (2021-2026) & (US$ Million)
Table 142. Global Heparin Sodium Revenue by Application (2027-2032) & (US$ Million)
Table 143. Global Heparin Sodium Revenue Market Share by Application (2021-2026)
Table 144. Global Heparin Sodium Revenue Market Share by Application (2027-2032)
Table 145. Global Heparin Sodium Price by Application (2021-2026) & (USD/Kg)
Table 146. Global Heparin Sodium Price by Application (2027-2032) & (USD/Kg)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Heparin Sodium Distributors List
Table 150. Heparin Sodium Customers List
Table 151. Heparin Sodium Industry Trends
Table 152. Heparin Sodium Industry Drivers
Table 153. Heparin Sodium Industry Restraints
Table 154. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Heparin Sodium Product Image
Figure 5. Global Heparin Sodium Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Heparin Sodium Market Size (2021-2032) & (US$ Million)
Figure 7. Global Heparin Sodium Sales (2021-2032) & (Kg)
Figure 8. Global Heparin Sodium Average Price (USD/Kg) & (2021-2032)
Figure 9. Oral Type Product Image
Figure 10. Injection Type Product Image
Figure 11. Treatment of Venous Thromboembolism Product Image
Figure 12. Complications of Pregnancy Product Image
Figure 13. Cardioversion of Atrial Fibrillation/Flutter Product Image
Figure 14. Other Product Image
Figure 15. Global Heparin Sodium Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Heparin Sodium, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Heparin Sodium Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Heparin Sodium Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Heparin Sodium Sales by Region in 2025
Figure 21. Global Heparin Sodium Revenue by Region in 2025
Figure 22. North America Heparin Sodium Market Size by Country in 2025
Figure 23. North America Heparin Sodium Sales Market Share by Country (2021-2032)
Figure 24. North America Heparin Sodium Revenue Market Share by Country (2021-2032)
Figure 25. United States Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Mexico Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 28. Europe Heparin Sodium Market Size by Country in 2025
Figure 29. Europe Heparin Sodium Sales Market Share by Country (2021-2032)
Figure 30. Europe Heparin Sodium Revenue Market Share by Country (2021-2032)
Figure 31. Germany Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. France Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. U.K. Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Italy Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Russia Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. Spain Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. Netherlands Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Switzerland Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Sweden Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Poland Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Asia Pacific Heparin Sodium Market Size by Country in 2025
Figure 42. Asia Pacific Heparin Sodium Sales Market Share by Country (2021-2032)
Figure 43. Asia Pacific Heparin Sodium Revenue Market Share by Country (2021-2032)
Figure 44. China Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Japan Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South Korea Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 47. India Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 48. Australia Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Taiwan Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Southeast Asia Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Southeast Asia Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. South America Heparin Sodium Market Size by Country in 2025
Figure 53. South America Heparin Sodium Sales Market Share by Country (2021-2032)
Figure 54. South America Heparin Sodium Revenue Market Share by Country (2021-2032)
Figure 55. Brazil Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Argentina Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. Chile Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Colombia Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 59. Middle East and Africa Heparin Sodium Market Size by Country in 2025
Figure 60. Middle East and Africa Heparin Sodium Sales Market Share by Country (2021-2032)
Figure 61. Middle East and Africa Heparin Sodium Revenue Market Share by Country (2021-2032)
Figure 62. Egypt Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 63. South Africa Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 64. Israel Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 65. Türkiye Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. GCC Countries Heparin Sodium Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Global Heparin Sodium Sales Market Share by Type (2021-2032)
Figure 68. Global Heparin Sodium Revenue Market Share by Type (2021-2032)
Figure 69. Global Heparin Sodium Price (USD/Kg) by Type (2021-2032)
Figure 70. Global Heparin Sodium Sales Market Share by Application (2021-2032)
Figure 71. Global Heparin Sodium Revenue Market Share by Application (2021-2032)
Figure 72. Global Heparin Sodium Price (USD/Kg) by Application (2021-2032)
Figure 73. Heparin Sodium Value Chain
Figure 74. Heparin Sodium Production Mode & Process
Figure 75. Direct Comparison with Distribution Share
Figure 76. Distributors Profiles
Figure 77. Heparin Sodium Industry Opportunities and Challenges
提及公司
Shenzhen HepalinkBioibéricaNanjing King-friendPfizerDongcheng BiochemicalsChangzhou Qianhong Bio-pharmaChangshan BiochemicalPharma ActionBaxterDongying Tiandong PharmaceuticalOpocrinAspen OssXinbai PharmaceuticalsYino Pharma LimitedSichuan Deebio
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們